COSMO Pharmaceuticals (Switzerland) Insiders
| COPN Stock | CHF 63.20 0.40 0.64% |
COSMO Pharmaceuticals employs about 292 people. The company is managed by 10 executives with a total tenure of roughly 682 years, averaging almost 68.0 years of service per executive, having 29.2 employees per reported executive. Recap of COSMO Pharmaceuticals' management performance can provide insight into the venture performance.
| Niall Donnelly Insider Chief Officer |
| Biagio Vigano Insider Chief Officer |
COSMO |
COSMO Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.0181 % which means that it generated a profit of $0.0181 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0841 %, meaning that it generated $0.0841 on every $100 dollars invested by stockholders. COSMO Pharmaceuticals' management efficiency ratios could be used to measure how well COSMO Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.COSMO Pharmaceuticals Workforce Comparison
COSMO Pharmaceuticals SA is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is currently estimated at about 595. COSMO Pharmaceuticals totals roughly 292 in number of employees claiming about 49% of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.45 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. COSMO Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. COSMO Pharmaceuticals Price Series Summation is a cross summation of COSMO Pharmaceuticals price series and its benchmark/peer.
COSMO Pharmaceuticals Notable Stakeholders
A COSMO Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as COSMO Pharmaceuticals often face trade-offs trying to please all of them. COSMO Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting COSMO Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Niall Donnelly | Chief Officer | Profile | |
| Biagio Vigano | Chief Officer | Profile | |
| Davide Malavasi | Qualified Director | Profile | |
| Marco Lecchi | Chief Officer | Profile | |
| Luigi Longo | Chief Officer | Profile | |
| Hazel Winchester | Head Relations | Profile | |
| Giulio Evangelisti | AI Production | Profile | |
| Alessandro LLM | CEO Director | Profile | |
| Ngo Nhan | Head IT | Profile | |
| Mauro Ajani | Founder Chairman | Profile |
About COSMO Pharmaceuticals Management Performance
The success or failure of an entity such as COSMO Pharmaceuticals often depends on how effective the management is. COSMO Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of COSMO management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the COSMO management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. It employs 306 people.
Please note, the imprecision that can be found in COSMO Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of COSMO Pharmaceuticals SA. Check COSMO Pharmaceuticals' Beneish M Score to see the likelihood of COSMO Pharmaceuticals' management manipulating its earnings.
COSMO Pharmaceuticals Workforce Analysis
Traditionally, organizations such as COSMO Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare COSMO Pharmaceuticals within its industry.COSMO Pharmaceuticals Manpower Efficiency
Return on COSMO Pharmaceuticals Manpower
| Revenue Per Employee | 222.9K | |
| Revenue Per Executive | 6.5M | |
| Net Income Per Employee | 74.2K | |
| Net Income Per Executive | 2.2M |
Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.